Principal Financial Group’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $99.4K | Buy |
|
|||||
|
2024
Q4 | $174K | Buy |
|
|||||
|
2024
Q3 | $267K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $223K | Sell |
|
|||||
|
2023
Q4 | $101K | Sell |
|
|||||
|
2023
Q3 | $82.9K | Buy |
|
|||||
|
2023
Q2 | $93.2K | Buy |
|
|||||
|
2023
Q1 | $54.9K | Sell |
|
|||||
|
2022
Q4 | $56.9K | Buy |
|
|||||
|
2022
Q3 | $150K | Sell |
|
|||||
|
2022
Q2 | $160K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $455K | Buy |
|
|||||
|
2021
Q2 | $339K | Buy |
|
|||||
|
2021
Q1 | $269K | Sell |
|
|||||
|
2020
Q4 | $792K | Buy |
|
|||||
|
2020
Q3 | $319K | Sell |
|
|||||
|
2020
Q2 | $590K | Buy |
|